Operating at the nexus of science and technology, DLH continues to deliver advanced solutions to the medical community
ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security, today announced that it has been awarded a five year task order valued at up to $37.7 million to continue delivering scientific research and development (R&D), modeling & simulation, artificial intelligence, machine learning, robotic process automation, biomedical engineering, and cloud-enabled big data analytic solutions for the Telemedicine and Advanced Technology Research Center (“TATRC”), a direct reporting unit of the US Army Medical Research & Development Command (“MRDC”). As a hub for developing next generation medical concepts and capabilities, TATRC & MRDC are focused on fusing data, humans, and machines to improve the medical outcomes of military service members around the world.
“For twenty years, DLH has partnered with the medical research & development community to address readiness challenges at the nexus of technology and scientific research,” said Zach Parker, DLH President and CEO. “The strength of this long-standing partnership underscores the ability of our industry-leading engineers, researchers, and technologists to provide impactful, mission-critical solutions. DLH incorporates our technical solutions to efficiently meet the evolving needs of warfighters, ensuring operational readiness from modeling and simulation to the battlefield.”
This $37.7 million contract was awarded as a task order under the OMNIBUS IV procurement vehicle. In this award, DLH will leverage its comprehensive suite of technology-enabled research and advanced engineering solutions, including software engineering, modeling and simulation, AI modeling, bioengineering, hybrid cloud architecture, and cyber security.
“TATRC and MRDC recognize DLH as an industry leader in information systems, scientific research & development, artificial intelligence, machine learning and robotic process automation plus clinical networks and research. We are transforming medical and scientific research, merging it with technology to optimize military health systems,” stated Dr. Vicki Hart, DLH Strategic Account Executive for Science, Research & Development markets.
“We are confident that the cutting-edge capabilities we deploy on behalf of the military’s vital missions position us well for similarly aligned pursuits across the military health and adjacent markets,” Parker continued.
About DLH
DLH (NASDAQ: DLHC), a Russell 2000 company, enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by customers today, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,400 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of technology, innovation, and world-class expertise, to improve lives across the globe. For more information, visit www.DLHcorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the risk that we will not realize the anticipated benefits of acquisitions (including anticipated future financial performance and results); the diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and more widespread operations; the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2024 as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.
Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.
